Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2005
09/21/2005EP1576877A1 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576368A2 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation
09/21/2005EP1576179A2 Methods and compositions for inducing apoptosis in cancer cells
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576158A2 Actinobacillus pleuropneumoniae virulence genes
09/21/2005EP1576143A2 Virus-like particles, methods of preparation, and immonogenic compositions
09/21/2005EP1576125A2 Activation of hcv-specific cells
09/21/2005EP1576122A2 Isolated mammalian membrane protein genes; related reagents
09/21/2005EP1576119A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
09/21/2005EP1576113A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
09/21/2005EP1576110A2 Cell migration inhibiting compositions and methods and compositions for treating cancer
09/21/2005EP1576105A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
09/21/2005EP1576100A2 Purified composition of bispecific molecules and methods of production
09/21/2005EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576011A2 Inhibition of il-17 production
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1576002A2 Peptide oligomers for use as hiv vaccines
09/21/2005EP1575993A2 Methods for treating patients and identifying therapeutics
09/21/2005EP1575985A2 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS
09/21/2005EP1575979A2 West nile virus vaccine
09/21/2005EP1575615A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same
09/21/2005EP1575613A1 Trivalent vaccine with maternal antibody transfer via the milk
09/21/2005EP1575612A1 Immunogenic composition
09/21/2005EP1575611A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy
09/21/2005EP1575610A1 Live attenuated vaccine against porcine pleuropneumonia
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575601A1 Recombinant vaccine viruses expressing il-15 and methods of using the same
09/21/2005EP1575571A2 Compositions and methods for the diagnosis and treatment of tumor
09/21/2005EP1575570A2 Transdermal vaccine delivery device having coated microprotrusions
09/21/2005EP1575531A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-&bgr;
09/21/2005EP1575529A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
09/21/2005EP1575526A2 Dna vaccines encoding heat shock proteins
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575522A2 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same
09/21/2005EP1575517A2 Anti-ngf antibodies and methods using same
09/21/2005EP1575516A2 Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
09/21/2005EP1575514A2 Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575508A2 Compositions and methods for the intracellular delivery of antibodies
09/21/2005EP1575505A2 Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
09/21/2005EP1575504A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
09/21/2005EP1575503A2 Compositions and methods for treating and preventing infection
09/21/2005EP1575500A2 Mesothelin vaccines and model systems
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575491A2 Treatment of renal carcinoma using antibodies against the egfr
09/21/2005EP1575484A2 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
09/21/2005EP1575483A2 Attenuated gram negative bacteria
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575417A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1263936B1 Altered strain of the modified vaccinia virus ankara (mva)
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
09/21/2005EP1087791B1 Inhibition of xenoreactive antibodies
09/21/2005EP0846171B1 Chromosome 1 gene and gene products related to alzheimer's disease
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0776337B1 Growth differentiation factor-11
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671851A Flavivirus vaccine delivery system
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671844A Antigenic neisserial peptides
09/21/2005CN1671837A Neutralizing human anti-IGFR antibody
09/21/2005CN1671742A Use of HMGB1 in the treatment of tissue damage and/or to promote tissue repair
09/21/2005CN1671741A Buffered formulations for concentrating antibodies and methods of use thereof
09/21/2005CN1671733A Compositions and methods for WT1 specific immunotherapy
09/21/2005CN1671722A Campylobacter glycans and glycopeptides
09/21/2005CN1671423A Novel chimeric CD154
09/21/2005CN1671417A Anti-myelin associated glycoprotein (MAG) antibodies
09/21/2005CN1671416A Super humanized antibodies
09/21/2005CN1671415A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
09/21/2005CN1671414A CpG formulations and related methods
09/21/2005CN1671413A Vaccine composition comprising transferrin bindin derived from gram-negative bacteria and HSF
09/21/2005CN1671412A Immunostimulatory compositions and methods of stimulating an immune response
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1670188A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
09/21/2005CN1669584A Process for preparing viral and bacterial vaccine for animals utilizing vegetable oil adjuvant
09/21/2005CN1219882C Method and combination for treating tumors based on ERBB-3
09/20/2005US6946490 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
09/20/2005US6946448 In utero oral nucleic acid immunization
09/20/2005US6946444 Modify the activity of the lipolysis stimulated receptor and can be used to influence the partitioning of dietary lipids between the liver and peripheral tissues; treating obesity-related insulin resistance
09/20/2005US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles)
09/20/2005US6946289 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
09/20/2005US6946264 DNA codes for polypeptides having amino acid sequences used as metalloenzyme inhibitors, for prophylaxis of autoimmune diseases or as wound healing agents
09/20/2005US6946256 Cell regulatory genes, encoded products, and uses related thereto
09/20/2005US6946245 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
09/20/2005US6946244 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
09/20/2005US6946136 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (HPIV-2) and vaccines based on such virus
09/20/2005US6946135 Prevention and treatment of amyloidogenic disease
09/20/2005US6946134 improved shelf-life; produced in glycosylation-/protease-free yeast cultures
09/20/2005US6946133 Prostate specific antigen oligo-epitope peptide
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
09/20/2005US6946131 Comprises heparan sulfate proteoglyeans; antiproliferative agents
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946126 Replicating adenovirus vectors
09/20/2005CA2189882C Papillomavirus vaccines
1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 1823